Viewing data from:

CARMUSTINE

ANDA

CARMUSTINE | A214814 | MSN LABORATORIES PRIVATE LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: BICNU(TE code: AP)

API Supply Chain12 active DMFs1 inactive

12 active API suppliers hold Drug Master Files for this ingredient.

JOHNSON MATTHEY PHARMACEUTICAL MATERIALSCARMUSTINE

DMF 102901993

AMPAC FINE CHEMICALS LLCCARMUSTINE (BCNU)

DMF 131691998

CHEMPACIFIC CORPCARMUSTINE DRUG SUBSTANCE

DMF 226372009

EMCURE PHARMACEUTICALS LTDCARMUSTINE USP

DMF 229052009

AGNO PHARMACARMUSTINE USP

DMF 301842017

MSN LABORATORIES PRIVATE LTDCARMUSTINE USP

DMF 311562016

JIANGSU HENGRUI PHARMACEUTICALS CO LTDCARMUSTINE USP NON STERILE BULK DRUG SUBSTANCE

DMF 320312017

APITORIA PHARMA PRIVATE LTDCARMUSTINE USP

DMF 323432017

NERPHARMA SRLCARMUSTINE DRUG SUBSTANCE

DMF 329222018

INTAS PHARMACEUTICALS LTDCARMUSTINE USP

DMF 337302019

NATCO PHARMA LTDCARMUSTINE

DMF 345472020

VANNSH LIFE SCIENCES PRIVATE LTDCARMUSTINE USP

DMF 386862023

BRISTOL LABORATORIES INC DIV BRISTOL MYERS COInactiveCARMUSTINE (BCNU) BULK & CARMUSTINE (BCNU) FOR INJ

DMF 20381973

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 100MG/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: May 11, 2023

No patent or exclusivity listings for this strength.